Literature DB >> 2010373

Flow redistribution during progressive hemorrhage is a determinant of critical O2 delivery.

R Schlichtig1, D J Kramer, M R Pinsky.   

Abstract

O2 consumption (VO2) of anesthetized whole mammals is independent of O2 delivery (DO2) until DO2 declines to a critical value (DO2c). Below this value, VO2 becomes O2 supply dependent. We assessed the influence of whole body DO2 redistribution among organs with respect to the commencement of O2 supply dependency. We measured DO2, VO2, and DO2c of whole body, liver, intestine, kidney, and remaining carcass in eight mongrel dogs during graded progressive hemorrhage. Whole body DO2 was redistributed such that the organ-to-whole body DO2 ratio declined for liver and kidney and increased for carcass. We then created a mathematical model wherein each organ-to-whole body DO2 ratio remained approximately constant at all values of whole body DO2 and assigned organ VO2 to predicted organ DO2 by interpolation and extrapolation of observed VO2-DO2 plots. The model predicted that O2 supply dependency without redistribution would have commenced at a higher value of whole body DO2 for whole body (8.11 +/- 0.89 vs. 6.98 +/- 1.16 ml.kg-1.min-1, P less than 0.05) and carcass (6.83 +/- 1.16 vs. 5.06 +/- 1.15 ml.kg-1.min-1, P less than 0.01) and at a lower value of whole body DO2 for liver (6.33 +/- 1.86 vs. 7.59 +/- 1.95, ml.kg-1.min-1, P less than 0.02) and kidney (1.25 +/- 0.64 vs. 4.54 +/- 1.29 ml.kg-1.min-1, P less than 0.01). We conclude that redistribution of whole body DO2 among organs facilitates whole body O2 regulation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2010373     DOI: 10.1152/jappl.1991.70.1.169

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  17 in total

1.  In search of the dysoxic threshold.

Authors:  R Schlichtig
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

Review 2.  Regional blood flow and hemorrhage. How far do the protective mechanisms go?

Authors:  M Hemmer
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

3.  Physiologic responses to severe hemorrhagic shock and the genesis of cardiovascular collapse: can irreversibility be anticipated?

Authors:  Hernando Gómez; Jaume Mesquida; Linda Hermus; Patricio Polanco; Hyung Kook Kim; Sven Zenker; Andrés Torres; Rajaie Namas; Yoram Vodovotz; Gilles Clermont; Juan Carlos Puyana; Michael R Pinsky
Journal:  J Surg Res       Date:  2012-03-10       Impact factor: 2.192

Review 4.  Beyond global oxygen supply-demand relations: in search of measures of dysoxia.

Authors:  M R Pinsky
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

Review 5.  Specific Etiologies Associated With the Multiple Organ Dysfunction Syndrome in Children: Part 2.

Authors:  Jeffrey S Upperman; John C Bucuvalas; Felicia N Williams; Bruce A Cairns; Charles S Cox; Allan Doctor; Robert F Tamburro
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

6.  Delaying blood transfusion in experimental acute anemia with a perfluorocarbon emulsion.

Authors:  Pedro Cabrales; Juan Carlos Briceño
Journal:  Anesthesiology       Date:  2011-04       Impact factor: 7.892

7.  Diffuse optical monitoring of peripheral tissues during uncontrolled internal hemorrhage in a porcine model.

Authors:  Karthik Vishwanath; Rajan Gurjar; David Wolf; Suzannah Riccardi; Michael Duggan; David King
Journal:  Biomed Opt Express       Date:  2018-01-11       Impact factor: 3.732

Review 8.  Oxygen transport-the oxygen delivery controversy.

Authors:  Jean-Louis Vincent; Daniel De Backer
Journal:  Intensive Care Med       Date:  2004-07-16       Impact factor: 17.440

9.  Fluid management in the critically ill child.

Authors:  Sainath Raman; Mark J Peters
Journal:  Pediatr Nephrol       Date:  2013-01-30       Impact factor: 3.714

Review 10.  [Evidence-based intensive care medicine. Practice, use and significance].

Authors:  J Graf; U Janssens
Journal:  Anaesthesist       Date:  2004-03       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.